Access cutting-edge epileptic encephalopathy treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access epileptic encephalopathy specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epileptic encephalopathy treatment provided free
This is a Phase 2, double-blind, randomized clinical trial to explore the safety, tolerability, efficacy, and pharmacokinetics of PRAX-562 in pediatric participants who have seizures associated with early-onset SCN2A-DEE and SCN8A-DEE.
Sponsor: Praxis Precision Medicines
Check if you qualify for this epileptic encephalopathy clinical trial in Chicago, IL
If you're searching for epileptic encephalopathy treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epileptic encephalopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.